#1 Clinical Trials Search in Europe

Metoprolol Tartrate

Metoprolol tartrate, a beta-blocker medication, has been the subject of several clinical trials investigating its effects on various cardiovascular conditions. These studies aim to evaluate the drug’s efficacy in managing heart rate, blood pressure, and potential cardioprotective properties in different patient populations and clinical scenarios.

Table of Contents

What is Metoprolol Tartrate?

Metoprolol tartrate is a medication that belongs to a class of drugs called beta-blockers. It is commonly used to treat various heart-related conditions and has been approved by the U.S. Food and Drug Administration (FDA)[1]. This medication is also known by several other names, including:

Metoprolol tartrate is available in tablet form for oral administration and can also be given intravenously (through a vein) in certain medical settings[1].

Conditions Treated with Metoprolol Tartrate

Metoprolol tartrate is used to treat a variety of cardiovascular conditions. Some of the primary conditions it is prescribed for include:

  • Atrial Fibrillation: A heart rhythm disorder characterized by irregular and often rapid heartbeat[4]
  • High Blood Pressure: Also known as hypertension, this condition can lead to various cardiovascular problems if left untreated[5]
  • Angina: Chest pain caused by reduced blood flow to the heart[6]
  • Heart Failure: A condition where the heart cannot pump blood effectively[6]
  • Premature Ventricular Contractions: Extra, abnormal heartbeats that begin in the heart’s lower chambers[6]
Additionally, metoprolol tartrate is sometimes used to prevent migraines and reduce the risk of future heart problems in patients who have had a heart attack[5].

How Metoprolol Tartrate Works

Metoprolol tartrate is a heart-selective beta-blocker. This means it primarily affects the heart and blood vessels. Here’s how it works:

  • Heart Rate Control: It slows down the heart rate by blocking the effects of adrenaline and other stress hormones on the heart[4]
  • Blood Pressure Reduction: By reducing the workload on the heart and relaxing blood vessels, it helps lower blood pressure[5]
  • Improved Heart Function: In heart failure patients, it can help the heart pump more efficiently[6]
  • Arrhythmia Management: It helps control irregular heartbeats by regulating the heart’s electrical activity[6]
By these actions, metoprolol tartrate helps improve overall heart function and reduces the strain on the cardiovascular system.

Dosage and Administration

The dosage of metoprolol tartrate can vary depending on the condition being treated and the individual patient’s response. Some common dosing regimens include:

  • For high blood pressure or angina: Starting dose is often 50 mg twice daily, which may be increased gradually if needed[2]
  • For heart rate control in atrial fibrillation: Doses may range from 25 mg to 100 mg twice daily[4]
  • For heart attack prevention: 25 mg to 50 mg every 6 hours in the early treatment phase[5]
It’s crucial to take metoprolol tartrate exactly as prescribed by your healthcare provider. Do not stop taking the medication suddenly without consulting your doctor, as this can lead to serious side effects[5].

Potential Side Effects

Like all medications, metoprolol tartrate can cause side effects. Common side effects may include:

  • Fatigue or weakness
  • Dizziness
  • Slow heart rate (bradycardia)
  • Low blood pressure
  • Cold hands and feet
  • Nausea or stomach discomfort
In some cases, more serious side effects can occur. These may include severe allergic reactions, worsening of heart failure symptoms, or severe dizziness. If you experience any severe or persistent side effects, contact your healthcare provider immediately[5].

Current Research and Clinical Trials

Metoprolol tartrate continues to be the subject of ongoing research to explore its potential benefits in various medical conditions. Some current areas of study include:

  • Septic Shock: Researchers are investigating whether intravenous metoprolol can improve outcomes in patients with septic shock due to ventilator-associated pneumonia[1]
  • Perioperative Myocardial Injury: Studies are examining if metoprolol can reduce heart-related complications in patients with coronary artery disease undergoing surgery[5]
  • Combination Therapy: Some trials are looking at the effectiveness of combining metoprolol tartrate with traditional Chinese medicine for treating premature ventricular contractions[6]
  • Interstitial Cystitis: Research is exploring whether metoprolol can help manage symptoms of interstitial cystitis, a chronic bladder condition[7]
These ongoing studies may lead to new applications or improved treatment strategies using metoprolol tartrate in the future.

Aspect Details
Main Uses in Trials Heart rate control, blood pressure management, potential cardioprotection
Conditions Studied Atrial fibrillation, acute myocardial infarction, anthracycline-induced cardiomyopathy
Administration Methods Oral tablets, intravenous injection
Key Outcomes Measured Heart rate, blood pressure, ejection fraction, infarct size
Potential Benefits Improved heart rate control, reduced myocardial damage, better cardiac imaging quality
Safety Monitoring Bradycardia, hypotension, other cardiovascular effects

FAQ

  • What is Metoprolol tartrate used for in clinical trials? Metoprolol tartrate is being studied for various cardiovascular conditions, including atrial fibrillation, heart rate control during computed tomography coronary angiography (CCTA), prevention of anthracycline-induced cardiomyopathy, and potential cardioprotection during acute myocardial infarction.
  • How does Metoprolol tartrate work? Metoprolol tartrate is a beta-blocker that works by blocking the effects of adrenaline on the heart. It helps to slow down heart rate, reduce blood pressure, and decrease the workload on the heart.
  • Are there any side effects of Metoprolol tartrate? Common side effects may include dizziness, tiredness, and slow heart rate. In some trials, researchers monitor for potential side effects such as symptomatic hypotension (low blood pressure) and bradycardia (abnormally slow heart rate).
  • How is Metoprolol tartrate administered in clinical trials? The administration of Metoprolol tartrate varies depending on the study. It may be given orally as tablets or intravenously. Dosages and timing of administration are carefully controlled and monitored in clinical trial settings.
  • What are some of the outcomes being measured in Metoprolol tartrate trials? Trials are measuring various outcomes, including heart rate control, blood pressure changes, effects on cardiac function (such as ejection fraction), impact on myocardial infarct size, and potential cardioprotective effects in different clinical scenarios.

Ongoing Clinical Trials on Metoprolol Tartrate

  • Study on Heart Health in Type 2 Diabetes Patients Using Semaglutide and Dapagliflozin Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on the Effects of Metoprolol in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Metoprolol for Preventing Heart Disease in Boys with Duchenne Muscular Dystrophy Aged 8-17

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Early Ablation and Use of Amiodarone, Beta-Blockers, or Sotalol for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on the Effects of Metoprolol Tartrate for Patients with Chronic Obstructive Pulmonary Disease (COPD) Without Cardiovascular Disease

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark France Germany Hungary Italy The Netherlands +1

Glossary

  • Atrial Fibrillation: An irregular and often rapid heart rhythm that can lead to blood clots in the heart.
  • Beta-blocker: A class of medications that block the effects of adrenaline on the heart, slowing heart rate and reducing blood pressure.
  • Cardiomyopathy: A group of diseases that affect the heart muscle, making it harder for the heart to pump blood to the rest of the body.
  • Computed Tomography Coronary Angiography (CCTA): A non-invasive imaging test that uses CT technology to visualize the coronary arteries.
  • Ejection Fraction: A measurement of how much blood the left ventricle pumps out with each contraction.
  • Infarct Size: The amount of heart muscle damage that occurs during a heart attack.
  • Myocardial Infarction: The medical term for a heart attack, which occurs when blood flow to the heart is blocked.
  • Placebo: An inactive substance or treatment used in clinical trials to compare results with the active drug being studied.
  • Reperfusion: The restoration of blood flow to an organ or tissue after it has been blocked.
  • Ventricular Rate: The speed at which the lower chambers of the heart (ventricles) beat.

References

  1. https://clinicaltrials.gov/study/NCT06592547
  2. https://clinicaltrials.gov/study/NCT00648271
  3. https://clinicaltrials.gov/study/NCT05261464
  4. https://clinicaltrials.gov/study/NCT02251509
  5. https://clinicaltrials.gov/study/NCT03138603
  6. https://clinicaltrials.gov/study/NCT05008250
  7. https://clinicaltrials.gov/study/NCT03008382